See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:APLS
Delisted

Apellis Pharmaceuticals Stock Predictions

etoro logo Buy APLS
*Your capital is at risk
$41.03
+0 (+0%)
At Close: Jul 23, 2026
Forecast Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 6 Aug 2026
APLS Live board
Community Bull/Bear
Target Next close

Join the APLS prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

APLS Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in
Forecast Desk

3-Month Forecasts For APLS

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

APLS Predictions History

Predictor Target Session Target Price Accuracy
Community predictor Next session USD target Record locked
Ranked predictor Previous session Bullish/Bearish Score locked

See the prediction record

Register to view community history, predictor profiles, accuracy, scores, and your own prediction trail for APLS.

Create free account Log in
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Log in or create a free account to view and request 66-session forecasts for APLS.
  • Price path
  • Approved predictor
  • 3-month horizon
Create Free Account Log In To View Forecasts
ABOUT APELLIS PHARMACEUTICALS INC.
Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal ...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE